| [1] |
.
[J]. Clinical Focus, 2021, 36(4): 374-378.
|
| [2] |
.
[J]. Clinical Focus, 2012, 27(22): 2024-0.
|
| [3] |
.
[J]. CLINICAL FOCUS, 2011, 26(13): 1195-1195.
|
| [4] |
.
[J]. CLINICAL FOCUS, 2011, 26(6): 526-0.
|
| [5] |
.
[J]. CLINICAL FOCUS, 2010, 25(11): 1005-1007.
|
| [6] |
.
[J]. CLINICAL FOCUS, 2010, 25(3): 217-0.
|
| [7] |
.
[J]. CLINICAL FOCUS, 2009, 24(18): 1581-1581.
|
| [8] |
.
[J]. CLINICAL FOCUS, 2009, 24(17): 1481-1481.
|
| [9] |
.
[J]. CLINICAL FOCUS, 2008, 23(12): 895-896.
|
| [10] |
.
[J]. CLINICAL FOCUS, 2008, 23(10): 0-0.
|
| [11] |
.
[J]. CLINICAL FOCUS, 2007, 22(24): 1778-1780.
|
| [12] |
.
[J]. CLINICAL FOCUS, 2007, 22(23): 1677-0.
|
| [13] |
LI Zhong-xing;ZHANG Xin-hua;WANG Xiu-hua;MENG Xiao-jie.
Comparison of in vitro antibacterial activity of minocycline and doxycycline against Staphylococcus epidermidis
[J]. CLINICAL FOCUS, 2007, 22(22): 1610-1613.
|
| [14] |
.
[J]. CLINICAL FOCUS, 2006, 21(4): 233-233.
|
| [15] |
.
[J]. CLINICAL FOCUS, 2005, 20(22): 1263-1263.
|
